Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens
Part of paid clinical trials in Torrance, California.
- Sponsor
- Argus Research Center, Inc.
- Study ID
- NCT07006428
- Status
- Recruiting
Conditions
- Age Related Cataracts
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Clareon PanOptix or PanOptix Toric IOLs — DEVICEBilateral implantation of the Clareon PanOptix or PanOptix Toric IOLs.
- Comparable multifocal IOL — DEVICEBilateral implantation of a comparable multifocal IOL
Study Details
This is a two-part, multi-center, investigator-initiated clinical study comparing visual outcomes and patient satisfaction in subjects receiving bilateral implantation of either the Clareon PanOptix intraocular lens (IOL) or a comparable multifocal IOL. The study includes a retrospective/prospective pilot phase and a prospective, randomized comparison phase.
Key Dates
- Start date
- May 7, 2025
- Status verified
- May 2025
- Primary completion
- Oct 31, 2025
- Completion
- Nov 30, 2025
Study Design
- Enrollment
- 290 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Clareon PanOptix or PanOptix Toric IOLs
- Experimental: Comparable multifocal IOL
Primary Outcome Measure
Binocular photopic BCDVA (4m) [ Time Frame: 2.5 to 5 months postoperatively ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wolstan & Goldberg Eye Associates | Torrance | California | 90505 | |
| Tyson Eye | Cape Coral | Florida | 33904 | |
| North Georgia Eye Associates | Gainesville | Georgia | 30501 |
Find similar trials in Torrance, CA
Related Studies
- A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related CataractPHASE2 · Enrolling By Invitation · Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. · Scottsdale, Arizona